Plasma levels of liver-specific miR-122 is massively increased in a porcine cardiogenic shock model and attenuated by hypothermia

Shock

Volumn 37, Issue 2, 2012, Pages 234-238

  Andersson, Patrik ^a   Gidlöf, Olof ^a   Braun, Oscar Ö ^a   Götberg, Matthias ^a   Van Der Pals, Jesper ^a   Olde, Björn ^a   Erlinge, David ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cardiogenic shock; Micro RNA; miR 122; miR 208b; plasma

Indexed keywords

MICRORNA; MICRORNA 122; MICRORNA 208B; UNCLASSIFIED DRUG;

ACIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON DILATATION; BLOOD LEVEL; BODY TEMPERATURE; CARDIOGENIC SHOCK; CELL CULTURE; CONTROLLED STUDY; HYPOTHERMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIVER CELL; LIVER ISCHEMIA; MICRORNA 122 BLOOD LEVEL; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION; SWINE;

ACIDOSIS; ANIMALS; ANOXIA; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; HYPOTHERMIA; ISCHEMIA; LIVER; MICRORNAS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; SHOCK, CARDIOGENIC; SWINE;

EID: 84856138252     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31823f1811     Document Type: Article

References (30)

1. Leungand AK, Sharp PA: MicroRNAs: a safeguard against turmoil? Cell 130:581-585, 2007.
2. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ: miRBase: tools for microRNA genomics. Nucleic Acids Res 36:D154-D158, 2008. (Pubitemid 351149713)
3. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, et al.: A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401-1414, 2007. (Pubitemid 46970709)
4. GiladS, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, et al.: Serum microRNAs are promising novel biomarkers. PLoS One 3:e3148, 2008.
5. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova- Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, et al.: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105:10513-10518, 2008.
6. Dorn GW 2nd: MicroRNAs in cardiac disease. Transl Res 157:226-235, 2011.
7. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, et al.: Circulating microRNAs in patients with coronary artery disease. Circ Res 107:677-684, 2010.
8. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, et al.: Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108:5003-5008, 2011.
9. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, Rubino M, Carena MC, Spazzafumo L, De Simone M, et al.: Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 31:2765-2773, 2010.
10. Gidlof O, Andersson P, van der Pals J, Gotberg M, Erlinge D: Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology 118: 217-226, 2011.
11. Topkaraand VK, Mann DL: Role of MicroRNAs in cardiac remodeling and heart failure. Cardiovasc Drugs Ther 25:171-182, 2011.
12. Dong S, Cheng Y, Yang J, Li J, Liu X,Wang X, Wang D, Krall TJ, Delphin ES, Zhang C: MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 284:29514-29525, 2009.
13. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, et al.: MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324: 1710-1713, 2009.
14. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, et al.: Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341:625-634, 1999.
15. Gotberg M, van der Pals J, Olivecrona GK, Koul S, Erlinge D: Mild hypothermia reduces acute mortality and improves hemodynamic outcome in a cardiogenic shock pig model. Resuscitation 81:1190-1196, 2010.
16. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346:557-563, 2002. (Pubitemid 34438816)
17. Holzer M: Targeted temperature management for comatose survivors of cardiac arrest. N Engl J Med 363:1256-1264, 2010.
18. Gotberg M, Olivecrona GK, Engblom H, Ugander M, van der Pals J, Heiberg E, Arheden H, Erlinge D: Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size. BMC Cardiovasc Disord 8:7, 2008.
19. Dae MW, Gao DW, Sessler DI, Chair K, Stillson CA: Effect of endovascular cooling on myocardial temperature, infarct size, and cardiac output in humansized pigs. Am J Physiol Heart Circ Physiol 282:H1584-H1591, 2002. (Pubitemid 34654823)
20. Haleand SL, Kloner RA: Myocardial temperature in acute myocardial infarction: protection with mild regional hypothermia. Am J Physiol 273:H220-H227, 1997.
21. Ning XH, Xu CS, Song YC, Xiao Y, Hu YJ, Lupinetti FM, Portman MA: Hypothermia preserves function and signaling for mitochondrial biogenesis during subsequent ischemia. Am J Physiol 274:H786-H793, 1998.
22. Reddy AM, Zheng Y, Jagadeeswaran G, Macmil SL, Graham WB, Roe BA, Desilva U, Zhang W, Sunkar R: Cloning, characterization and expression analysis of porcine microRNAs. BMC Genomics 10:65, 2009.
23. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, Guo H, Fei M, Sun S: Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 56:1830-1838, 2010.
24. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ: Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 106:4402-4407, 2009.
25. Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, Johnson JM, Sina JF, Fare TL, Sistare FD, et al.: Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55:1977-1983, 2009.
26. Craxiand A, Almasio P: Diagnostic approach to liver enzyme elevation. J Hepatol 25(Suppl 1):47-51, 1996. (Pubitemid 26278412)
27. Prattand DS, Kaplan MM: Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 342:1266-1271, 2000. (Pubitemid 30235957)
28. Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, Shi Y, Peveling-Oberhag J, Radeke HH, Sarrazin C, Herrmann E, et al.: Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol 106:1663-1669, 2011.
29. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L: Circulating MicroRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 6:e23937, 2011.
30. Farid WR, Pan Q, van der Meer AJ, de Ruiter PE, Ramakrishnaiah V, de Jonge J, Kwekkeboom J, Janssen HL, Metselaar HJ, Tilanus HW, et al.: Hepatocytederived microRNAs as serum biomarker of hepatic injury and rejection after liver transplantation. Liver Transpl [epub ahead of print Sep 19, 2011].